Strategies to prevent the next pandemic fall into two main categories:

1. Prevent or prepare for natural spillover

2. Prevent or prepare for man-made pathogens

This community has rightly focused on the second category. A pathogen that is naturally evolving has no incentive to be incredibly deadly- its only "goal" is to spread, and lethality is a by product. Humans, on the other hand, actively try to make pathogens more lethal and transmissible than they would otherwise be, sometimes for research intended to prevent illness and death, and occasionally to create bioweapons intended to kill and spread.  

In Toby Ord's The Precipice, he estimates the risk of an existential catastrophe from a "naturally" arising pandemic[1] in the next century is over 300 times less likely than that of an existential catastrophe from engineered pandemics. Our efforts should continue to focus on this relatively neglected tail which contributes much more to our civilization's risk of extinction or unrecoverable collapse. 

We should also continue to pressure people and organizations to not take actions that decrease the threat of 1 but increase the threat of 2; examples of these kinds of action include virus hunting, especially if the results are then categorized and posted online, and some of the research intentionally making pathogens more transmissible or deadly given our track record of unintentional lab leaks, even from BSL-4 labs

However, this correct focus on category 2 risks does not preclude reducing category 1 risks as well. We have seen how a mildly deadly pathogen like SARS-CoV-2 can cause tremendous harm and suffering, with Our World in Data reporting almost 7 million confirmed deaths worldwide. The origins of this virus are still debated, but many have argued that the mere plausibility that a virus like this could have come from a lab should be enough to act to prevent any future lab leak of a deadly and transmissible virus. I agree, and I think this logic also goes the other way: the mere plausibility of a pandemic virus capable of killing millions emerging naturally should be enough to motivate us to prevent and prepare for future pathogens of zoonotic origin, given those actions do not increase the risk from pathogens intentionally or unintentionally released by humans. 

This paper is focused on how we can reduce the risk of pathogen spillover, taking a category 1 approach. Here are some selected quotes from the article, along with my takeaways:
 

In many emerging infectious disease hotspots, little intact forest remains, and spillover events occur because dense human and domestic animal populations live closer to wildlife and commercial activities might involve intentional (e.g., wildlife trade) or unintentional contact with wildlife (26). Such areas make up only 4% of global area (10% of tropical area), but account for 60% of global spillover risk.

 

Actions to reduce local risk for zoonotic diseases can be simple. For example, Nipah virus infection risk can be reduced by covering the shaved areas of palm tree trunks and sap vessels, thus preventing contamination with excrement of bats that feed on these palms (28). Where contact cannot be eliminated, improved practices, such as better sanitary practices during wildlife butchering, can minimize spillover (29).

 

Controlling vaccine-preventable diseases in domestic animals also should be prioritized. Vaccination benefits communities and domestic animals through reduced illness and death from vaccine-targeted disease. Vaccination also reduces the spread of emerging infectious diseases because diagnosis can be delayed when emerging infectious diseases have similar clinical signs to vaccine-preventable diseases. For example, identification of highly pathogenic avian influenza in chickens frequently is delayed in areas with low Newcastle disease vaccination rates (45,47). Similarly, control for outbreaks of African swine fever (ASF), a disease with no effective vaccine, is hampered by low vaccination rates against classical swine fever (CSF) because the diseases have similar clinical signs, making ASF differentiation difficult in herds not vaccinated against CSF (48). In China, a 2019 pork shortage caused by ASF might have increased consumer demand for wildlife, thereby increasing the risk of pathogen spillover (2).

 

For pandemic prevention, the primary focus should be live and freshly butchered wild birds and mammals because those pose the highest risk for spillover.

 

In numerous countries, wildlife consumption, especially in urban centers, is not required for food security; rather, wildlife is consumed as a luxury, as a status symbol, or for perceived health reasons. In China, the price for wildlife is generally 2- to 5-fold higher than for pork, the most common animal protein source in the country, and even higher for exotic, endangered, or illegally obtained species (52,53). Reducing urban demand for wildlife will have a positive effect on IPLCs by reducing economic incentives to those supplying the trade and leaving more wildlife for IPLC subsistence needs. A strategy to ensure recognition and support of IPLC rights is vital, but that support must not be used as a smokescreen to continue business-as-usual in commercial markets and trade.

 

Many human febrile illnesses in low-income countries never reach the health system and are not thoroughly evaluated; thus, many viral infections are never diagnosed (61,62). 

 

Mounting evidence suggests that zoonotic pathogen spillover occurs more frequently than previously known. A study of exposure to batborne SARS-related coronaviruses suggested that ≈66,000 persons are infected with SARS-related coronaviruses annually in South and Southeast Asia (65).

My takeaways:

  • Even vaccinating for diseases that are unlikely to cause a pandemic, in both humans and animals, can help our response to pandemic capable pathogens, by eliminating diseases that cause similar symptoms and by making health and food systems more resilient.
  • Increasing sampling of pathogens in wildlife seems like a bad idea, but increasing surveillance of human diseases, especially undiagnosed human diseases, seems like an intervention that would have positive effects for the people being tested, for basic science, and for pandemic preparedness.
  • While reducing category 1 risks is important, we can't entirely eliminate the possibility of a natural pandemic. We need to continue investing in preparedness and response measures to mitigate the impact of such events, including global surveillance systems, vaccine development, and rapid deployment of medical supplies and personnel in the event of an outbreak.
  1. ^

    "Naturally" in quotation marks because it would still be spread by human inventions such as air travel, cities, etc

Comments


No comments on this post yet.
Be the first to respond.
Curated and popular this week
 ·  · 2m read
 · 
I can’t recall the last time I read a book in one sitting, but that’s what happened with Moral Ambition by bestselling author Rutger Bregman. I read the German edition, though it’s also available in Dutch (see James Herbert's Quick Take). An English release is slated for May. The book opens with the statement: “The greatest waste of our times is the waste of talent.” From there, Bregman builds a compelling case for privileged individuals to leave their “bullshit jobs” and tackle the world’s most pressing challenges. He weaves together narratives spanning historical movements like abolitionism, suffrage, and civil rights through to contemporary initiatives such as Against Malaria Foundation, Charity Entrepreneurship, LEEP, and the Shrimp Welfare Project. If you’ve been engaged with EA ideas, much of this will sound familiar, but I initially didn’t expect to enjoy the book as much as I did. However, Bregman’s skill as a storyteller and his knack for balancing theory and narrative make Moral Ambition a fascinating read. He reframes EA concepts in a more accessible way, such as replacing “counterfactuals” with the sports acronym “VORP” (Value Over Replacement Player). His use of stories and examples, paired with over 500 footnotes for details, makes the book approachable without sacrificing depth. I had some initial reservations. The book draws heavily on examples from the EA community but rarely engages directly with the movement, mentioning EA mainly in the context of FTX. The final chapter also promotes Bregman’s own initiative, The School for Moral Ambition. However, the school’s values closely align with core EA principles. The ITN framework and pitches for major EA cause areas are in the book, albeit with varying levels of depth. Having finished the book, I can appreciate its approach. Moral Ambition feels like a more pragmatic, less theory-heavy version of EA. The School for Moral Ambition has attracted better-known figures in Germany, such as the political e
MarieF🔸
 ·  · 4m read
 · 
Summary * After >2 years at Hi-Med, I have decided to step down from my role. * This allows me to complete my medical residency for long-term career resilience, whilst still allowing part-time flexibility for direct charity work. It also allows me to donate more again. * Hi-Med is now looking to appoint its next Executive Director; the application deadline is 26 January 2025. * I will join Hi-Med’s governing board once we have appointed the next Executive Director. Before the role When I graduated from medical school in 2017, I had already started to give 10% of my income to effective charities, but I was unsure as to how I could best use my medical degree to make this world a better place. After dipping my toe into nonprofit fundraising (with Doctors Without Borders) and working in a medical career-related start-up to upskill, a talk given by Dixon Chibanda at EAG London 2018 deeply inspired me. I formed a rough plan to later found an organisation that would teach Post-traumatic stress disorder (PTSD)-specific psychotherapeutic techniques to lay people to make evidence-based treatment of PTSD scalable. I started my medical residency in psychosomatic medicine in 2019, working for a specialised clinic for PTSD treatment until 2021, then rotated to child and adolescent psychiatry for a year and was half a year into the continuation of my specialisation training at a third hospital, when Akhil Bansal, whom I met at a recent EAG in London, reached out and encouraged me to apply for the ED position at Hi-Med - an organisation that I knew through my participation in their introductory fellowship (an academic paper about the outcomes of this first cohort can be found here). I seized the opportunity, applied, was offered the position, and started working full-time in November 2022.  During the role I feel truly privileged to have had the opportunity to lead High Impact Medicine for the past two years. My learning curve was steep - there were so many new things to
Sarah Cheng
 ·  · 2m read
 · 
TL;DR: The EA Opportunity Board is back up and running! Check it out here, and subscribe to the bi-weekly newsletter here. It’s now owned by the CEA Online Team. EA Opportunities is a project aimed at helping people find part-time and volunteer opportunities to build skills or contribute to impactful work. Their core products are the Opportunity Board and the associated bi-weekly newsletter, plus related promos across social media and Slack automations. It was started and run by students and young professionals for a long time, and has had multiple iterations over the years. The project has been on pause for most of 2024 and the student who was running it no longer has capacity, so the CEA Online Team is taking it over to ensure that it continues to operate. I want to say a huge thank you to everyone who has run this project over the three years that it’s been operating, including Sabrina C, Emma W, @michel, @Jacob Graber, and Varun. From talking with some of them and reading through their docs, I can tell that it means a lot to them, and they have some grand visions for how the project could grow in the future. I’m happy that we are in a position to take on this project on short notice and keep it afloat, and I’m excited for either our team or someone else to push it further in the future. Our plans We plan to spend some time evaluating the project in early 2025. We have some evidence that it has helped people find impactful opportunities and stay motivated to do good, but we do not yet have a clear sense of the cost-effectiveness of running it[1]. We are optimistic enough about it that we will at least keep it running through the end of 2025, but we are not currently committing to owning it in the longer term. The Online Team runs various other projects, such as this Forum, the EA Newsletter, and effectivealtruism.org. I think the likeliest outcome is for us to prioritize our current projects (which all reach a larger audience) over EA Opportunities, which